What's new

Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Status: Opinion

Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Status: Opinion

Apr 25, 2025 - 15:03
 0
Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Status: Opinion
Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Status: Opinion
Read More

Tags:

Previous Article

TIME Hotels to reveal bold growth strategy with 12 new openings by Q1 2026 durin...

Next Article

Orphan designation: octreotide hydrochloride Treatment of acromegaly, 12/06/200...

Related Posts

Business process description for regulatory and scienti...

Apr 22, 2025  0

Human medicines European public assessment report (EPAR): Attrogy, diflunisal, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Regkirona, regdanvimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0